GlassScriptPhysician profile
Aarthi Bawa
NPI 1396177291
$4,425.20
in general payments reported to CMS, 2019-2025
25 companies · $648 in 2025
The $648 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $339 · 2020: $363 · 2021: $854 · 2022: $780 · 2023: $855 · 2024: $585 · 2025: $648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,088.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $1,159.94 | 2019-2023 | Krystexxa |
| Smith+Nephew, INC. | $803.95 | 2020-2025 | Collagenase Santyl, Regranex, Grafix |
| Amgen INC. | $554.56 | 2024-2025 | Krystexxa |
| Abbvie INC. | $292.14 | 2021-2025 | Dalvance |
| Stryker Corporation | $265.82 | 2022-2023 | Actishield, Fuseforce |
| Inari Medical, INC. | $214.42 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Paratek Pharmaceuticals, INC. | $193.27 | 2024-2025 | Nuzyra |
| Cardiovascular Systems INC. | $187.36 | 2021-2022 | |
| Melinta Therapeutics, LLC | $184.44 | 2021-2022 | |
| Heron Therapeutics, INC. | $121.92 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $68.96 | 2025 | |
| Reflow Medical INC | $42.66 | 2025 | |
| Convatec INC. | $38.71 | 2021-2022 | |
| Bioventus LLC | $38.02 | 2019-2022 | |
| Cashflow Solutions, LLC | $36.51 | 2024-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $33.26 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Wright Medical Technology, INC. | $33.04 | 2020 | |
| Grt US Holding, INC. | $28.76 | 2022 | |
| Treace Medical Concepts, INC. | $25.50 | 2023 | |
| Organogenesis INC. | $24.71 | 2020 | |
| Hydrofera LLC | $19.72 | 2024 | Hydrofera Blue |
| Aroa Biosurgery Incorporated | $19.65 | 2023 | |
| Arthrosurface Incorporated | $13.55 | 2020 | |
| Medtronic, INC. | $13.15 | 2023 | Endurant Iis |
| Linvatec Corporation | $11.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aarthi Bawa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.